Jie Gan
Corporate Officer/Principal bei The Hong Kong University of Science & Technology
Aktive Positionen von Jie Gan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The Hong Kong University of Science & Technology | Corporate Officer/Principal | - | - |
Karriereverlauf von Jie Gan
Ehemalige bekannte Positionen von Jie Gan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
China Biologic Products, Inc.
 China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | - | 08.01.2010 |
Ausbildung von Jie Gan
| Peking University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Statistik
International
| China | 4 |
| Vereinigte Staaten | 2 |
| Hong Kong | 2 |
Operativ
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Health Technology |
